Cameron Turtle Bridge Bio Pharma, Inc. (BBIO) insider trading activity
Cameron Turtle is Officer of BridgeBio Pharma, Inc.. Currently has a direct ownership of 12,568 shares of BBIO, which is worth approximately $351,778. The most recent transaction as insider was on Dec 28, 2020, when has been sold 19,500 shares (Common Stock) at a price of $69.64 per share, resulting in proceeds of $1,357,980. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
12.6K
0%
3M change
0%
12M change
Total Value Held
$351,778
Cameron Turtle Transaction History
Also insider at
CT
Cameron Turtle
Officer
San Francisco, CA